Are you incorporating TTFields into treatment protocols for locally advanced pancreatic cancer based on the PANOVA-3 study?  

Most medical and radiation oncologists I have spoken to believe that TTFields offer benefit based on the PANOVA-3 trial and support routine use once it is FDA-approved. One of the outstanding questions relates to the use of definitive radiation therapy, which was not included in either arm, but is a...